InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,615.35
(
0.55%
)
US TECH 100
19,803.20
(
0.64%
)
Dow Jones
40,000.90
(
0.62%
)
Brent Oil
84.57
(
0.00%
)
Bitcoin
57,851.37
(
-0.07%
)

Replies to post #356 on Intercept Pharmaceuticals (ICPT)

Replies to #356 on Intercept Pharmaceuticals (ICPT)
icon url

DewDiligence

05/11/15 11:15 AM

#357 RE: oldsport #356

Not sure, insofar as there was nothing really new in the PR or CC. Still, re-iteration of guidance wrt final design of the phase-3 NASH trial is a positive.